Press release Flash Therapeutics (EN)

Vectalys & Flashcell merge and create Flash Therapeutics, a new gene therapy company.

Vectalys and FlashCell announced that they have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics.

Flash Therapeutics is a new company developing proprietary RNA-based therapeutics and providing broad lentiviral development, manufacturing expertise and support.

To learn more about this new company, discover the  press release .